Compare ALG & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALG | KNSA |
|---|---|---|
| Founded | 1955 | 2015 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 1993 | 2018 |
| Metric | ALG | KNSA |
|---|---|---|
| Price | $191.25 | $41.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $225.00 | $52.33 |
| AVG Volume (30 Days) | 111.4K | ★ 573.8K |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.64 | 0.47 |
| Revenue | ★ $1,615,388,000.00 | $597,973,000.00 |
| Revenue This Year | $1.26 | $61.60 |
| Revenue Next Year | $5.09 | $29.82 |
| P/E Ratio | ★ $19.57 | $87.89 |
| Revenue Growth | N/A | ★ 55.68 |
| 52 Week Low | $156.30 | $18.12 |
| 52 Week High | $233.29 | $44.42 |
| Indicator | ALG | KNSA |
|---|---|---|
| Relative Strength Index (RSI) | 66.83 | 53.97 |
| Support Level | $188.19 | $37.02 |
| Resistance Level | $195.17 | $39.74 |
| Average True Range (ATR) | 5.40 | 2.06 |
| MACD | 0.86 | -0.09 |
| Stochastic Oscillator | 86.77 | 76.11 |
Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial and agricultural use. Its products include tractor-mounted and self-propelled mowers, zero-turn mowers, agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, and snow removal equipment. The company's reportable segments are Vegetation Management and Industrial Equipment. It generates a majority of revenue from Vegetation Management. Geographically, it generates the majority of revenue from United States.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.